• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阳性淋巴细胞交叉配型和人类肝脏移植中HLA错配对小胆管消失综合征的影响。

Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts.

作者信息

Batts K P, Moore S B, Perkins J D, Wiesner R H, Grambsch P M, Krom R A

机构信息

Department of Laboratory Medicine, Mayo Clinic, Rochester, Minnesota 55905.

出版信息

Transplantation. 1988 Feb;45(2):376-9. doi: 10.1097/00007890-198802000-00026.

DOI:10.1097/00007890-198802000-00026
PMID:3278430
Abstract

Among the first 52 recipients of primary liver allografts with follow-up of 2 weeks or greater, 6 patients had biopsy-confirmed vanishing bile duct syndrome (VBDS) and required retransplantation. Five of these six patients had positive lymphocyte crossmatches. Of the 46 remaining liver transplant recipients, 11 had positive crossmatches. Thus, the incidence of VBDS was 5/16 in recipients with a positive crossmatch and 1/36 in recipients with a negative crossmatch. The positive-crossmatch group was significantly more likely to develop VBDS than the negative-crossmatch group (P less than 0.004, log rank test). Additional HLA studies comparing degree of donor-recipient mismatch at the various HLA loci showed no significant difference between the groups for class I disparity. However, class II mismatch was of borderline significance (P less than 0.056). When evaluated individually, the DQ mismatch (P less than 0.04) appeared to be more important than the DR mismatch (P = NS). Our data suggest that a positive lymphocyte crossmatch and a class II mismatch, in particular HLA DQ disparity, may play an important role in the pathogenesis of VBDS.

摘要

在首批52例接受同种异体原位肝移植且随访时间达2周或更长时间的患者中,6例经活检确诊为胆管消失综合征(VBDS)并需要再次移植。这6例患者中有5例淋巴细胞交叉配型呈阳性。在其余46例肝移植受者中,11例交叉配型呈阳性。因此,交叉配型阳性的受者中VBDS的发生率为5/16,交叉配型阴性的受者中VBDS的发生率为1/36。交叉配型阳性组比交叉配型阴性组发生VBDS的可能性显著更高(P<0.004,对数秩检验)。进一步比较供受者在各个HLA位点错配程度的HLA研究表明,两组在I类错配上无显著差异。然而,II类错配具有临界显著性(P<0.056)。单独评估时,DQ错配(P<0.04)似乎比DR错配(P=无显著性差异)更重要。我们的数据表明,淋巴细胞交叉配型阳性和II类错配,尤其是HLA DQ错配,可能在VBDS的发病机制中起重要作用。

相似文献

1
Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts.阳性淋巴细胞交叉配型和人类肝脏移植中HLA错配对小胆管消失综合征的影响。
Transplantation. 1988 Feb;45(2):376-9. doi: 10.1097/00007890-198802000-00026.
2
Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.1996 - 2011年东京大学活体供肝肝移植:HLA配型和阳性交叉配型对长期生存及免疫耐受的影响
Clin Transpl. 2011:223-35.
3
Positive pretransplant crossmatches predict early graft loss in liver allograft recipients.移植前交叉配型阳性预示肝移植受者早期移植物丢失。
Transplantation. 1994 Feb 27;57(4):616-20.
4
Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect".人类白细胞抗原匹配对肝移植存活及排斥反应的影响:“二元效应”
Hepatology. 1993 Jun;17(6):1008-15.
5
Influence of anti-HLA antibodies and positive T-lymphocytotoxic crossmatch on survival and graft rejection in human liver transplantation.抗HLA抗体和阳性T淋巴细胞毒性交叉配型对人肝移植患者生存率及移植物排斥反应的影响
J Hepatol. 1996 Apr;24(4):452-9. doi: 10.1016/s0168-8278(96)80166-8.
6
Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation.肝移植后出现的胆管消失综合征中针对HLA I类抗原免疫反应的证据。
Lancet. 1987 Apr 25;1(8539):945-51. doi: 10.1016/s0140-6736(87)90293-5.
7
The clinical significance of flow cytometry crossmatching in heart transplantation.流式细胞术交叉配型在心脏移植中的临床意义。
Eur J Cardiothorac Surg. 2000 Apr;17(4):362-9. doi: 10.1016/s1010-7940(00)00363-8.
8
Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation.巨细胞病毒感染与供体/受体人类白细胞抗原:肝移植后胆管消失综合征发病机制中的相互依存辅助因素。
Lancet. 1988 Aug 6;2(8606):302-5. doi: 10.1016/s0140-6736(88)92356-2.
9
Role of HLA compatibility in pediatric liver transplantation.HLA相容性在小儿肝移植中的作用。
Transplantation. 1998 Jul 15;66(1):53-8. doi: 10.1097/00007890-199807150-00009.
10
Renal allograft survival in patients with positive B cell crossmatch to their donor.对供体B细胞交叉配型呈阳性的患者的肾移植存活率。
Ann Surg. 1984 Jan;199(1):75-8. doi: 10.1097/00000658-198401000-00013.

引用本文的文献

1
Liver Transplantation in Recipients With a Positive Crossmatch: A Retrospective Single-Center Match-Pair Analysis.肝移植受者交叉配型阳性:回顾性单中心匹配对分析。
Transpl Int. 2023 Mar 2;36:11062. doi: 10.3389/ti.2023.11062. eCollection 2023.
2
Revisiting the liver's role in transplant alloimmunity.重新审视肝脏在移植免疫中的作用。
World J Gastroenterol. 2019 Jul 7;25(25):3123-3135. doi: 10.3748/wjg.v25.i25.3123.
3
Acute liver allograft antibody-mediated rejection: an inter-institutional study of significant histopathological features.
急性肝移植抗体介导的排斥反应:一项关于显著组织病理学特征的机构间研究。
Liver Transpl. 2014 Oct;20(10):1244-55. doi: 10.1002/lt.23948.
4
Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss.抗体介导的排斥反应是导致先前不明原因的早期肝移植失败的一个因素。
Liver Transpl. 2014 Feb;20(2):218-27. doi: 10.1002/lt.23788. Epub 2014 Jan 2.
5
The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.供者特异性 HLA 抗体在 ABO 血型相容肝移植中排斥反应和小胆管缺失发展中的意义。
Am J Transplant. 2011 Mar;11(3):500-10. doi: 10.1111/j.1600-6143.2010.03414.x.
6
Cytomegalovirus and chronic allograft rejection in liver transplantation.巨细胞病毒与肝移植中的慢性移植物排斥反应
World J Gastroenterol. 2004 Jul 1;10(13):1857-61. doi: 10.3748/wjg.v10.i13.1857.
7
Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years.他克莫司能否为初次肝移植后的慢性排斥反应提供几乎完全的预防?1048例肝移植患者的风险及预后因素分析,平均随访6年。
Liver Transpl. 2001 Jul;7(7):623-30. doi: 10.1053/jlts.2001.25364.
8
Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging.在以他克莫司作为基础免疫抑制进行主要治疗的人群中慢性肝移植排斥反应:长期随访及组织病理学分期特征评估
Transplantation. 2000 Jun 15;69(11):2330-6. doi: 10.1097/00007890-200006150-00019.
9
Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts.交叉配型阳性的人肝移植受者胆管并发症增加和/或发生慢性排斥反应。
Transplant Proc. 1999 Aug;31(5):2028-31. doi: 10.1016/s0041-1345(99)00256-0.
10
Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model.致敏受者的肝移植排斥反应。在临床相关小动物模型中的观察结果。
Am J Pathol. 1993 May;142(5):1383-91.